How countries are dealing with the delicate matter of who to vaccinate first

Dec 3, 2020

A medic fills a syringe with COVAXIN, an Indian government-backed experimental COVID-19 vaccine, before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society in Ahmedabad, India, November 26, 2020. REUTERS/Amit Dave - RC2YAK9TYO76

A medic fills a syringe with an experimental COVID-19 vaccine before administering it to a health worker during trials in Ahmedabad, India, November 26, 2020. Image: REUTERS/Amit Dave - RC2YAK9TYO76

John Letzing

Digital Editor, Strategic Intelligence, World Economic Forum

Our Impact

The Big Picture

Explore and monitor how COVID-19 is affecting economies, industries and global issues

A hand holding a looking glass by a lake

Crowdsource Innovation

Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

COVID-19

Image: World Economic Forum

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.